Skip to main content

Editas Medicine – Accumulation phase

Editas Medicine – Accumulation phase

Editas Medicine ( Nasdaq: $EDIT ) is a gene editing company at the leading edge of the revolutionary CRISPR technology. The rising exchange volumes on the weekly scale has the hallmarks of rising interest and shares accumulation, whereas the relative strength is also progressively rising and should soon turn positive. Last week the price broke […]

Turkish Lira – massively oversold against the US Dollar

Turkish Lira – massively oversold against the US Dollar

The $USDTRY pair appears to be extremely overbought on longer time frames, which in other terms means that the Turkish Lira is massively oversold against the Greenback. On the six-month time frame this overbought condition is accompanied by a shooting star candle, which is a strong indication that the uptrend should stall (for the least) […]

MAZOR Robotics (MZOR), a perfect long term biotech play

MAZOR Robotics (MZOR), a perfect long term biotech play

#Mazor Robotics (MZOR) appears to be a perfect Weinstein winner. The price broke out of its long term trading range in March 2017 with a strong volume increase and with a positive relative strength compared to the NASDAQ Composite Index. The current consolidation phase should soon give way to higher prices. Disclosure: I am long […]